Prot #CNTO1959PSO3003: A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Guselkumab for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

  • Gordon, Kenneth B (PD/PI)

Project: Research project

Project Details

Effective start/end date1/20/155/24/20


  • Janssen Research & Development, LLC (Prot #CNTO1959PSO3003)